Laurence Morand-Joubert Selected Research

Laurence Morand-Joubert Research Topics

4	Infections 01/2022 - 07/2015
3	COVID-19 01/2022 - 10/2020
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 05/2008
3	Hepatitis 01/2018 - 03/2009
2	Encephalitis (Encephalitis, Rasmussen) 01/2017 - 09/2010
2	Viremia 01/2014 - 01/2011
2	Coinfection 01/2014 - 03/2009
1	Critical Illness (Critically Ill) 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 10/2021
1	HIV Infections (HIV Infection) 01/2018
1	Meningoencephalitis 03/2009
1	Chronic Hepatitis B 03/2009
1	Chronic Hepatitis (Chronic Active Hepatitis) 03/2009
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2009
1	Fibrosis (Cirrhosis) 03/2009

4	RNA (Ribonucleic Acid)IBA 11/2018 - 05/2008
4	efavirenz (Sustiva)FDA Link 07/2015 - 03/2009
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2009
2	Pharmaceutical PreparationsIBA 01/2018 - 07/2009
2	Tenofovir (Viread)FDA Link 01/2011 - 07/2009
1	IntegrasesIBA 01/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2022
1	NucleosidesIBA 01/2022
1	Reverse Transcriptase InhibitorsIBA 01/2022
1	BNT162 VaccineIBA 10/2021
1	COVID-19 VaccinesIBA 10/2021
1	VaccinesIBA 10/2021
1	Immunoglobulin G (IgG)IBA 10/2020
1	AntibodiesIBA 10/2020
1	Rilpivirine (TMC-278)IBA 01/2018
1	Viral RNAIBA 01/2017
1	Interleukin-10 (Interleukin 10)IBA 01/2014
1	Nevirapine (Viramune)FDA Link 01/2011
1	Emtricitabine (Emtriva)FDA Link 01/2011
1	Lamivudine (Epivir)FDA Link 07/2009
1	etravirine (TMC-125)FDA Link 03/2009
1	Lopinavir FDA Link 05/2008
1	amprenavir (Agenerase)FDA Link 05/2008

3	Therapeutics 01/2017 - 03/2009